Panugan, Felipe M.

HRN: 04-40-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2022
CEFTRIAXONE 1G (VIAL)
04/16/2022
04/23/2022
IV
2g
Q12
Bacterial Meningitis
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: